Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Jun;52(6):461–463. doi: 10.1136/ard.52.6.461

Beta 2 microglobulin measurements in saliva of patients with primary Sjögren's syndrome: influence of flow.

S A van der Geest 1, H M Markusse 1, A J Swaak 1
PMCID: PMC1005073  PMID: 8323400

Abstract

OBJECTIVES--To determine the diagnostic value of beta 2 microglobulin in parotid saliva, its concentration in relation to salivary flow was determined in 29 patients with primary Sjögren's syndrome and in 30 normal controls. The specific secretion rate of beta 2 microglobulin was calculated. METHODS--Parotid saliva samples were collected within a 20 minute period directly from Stensen's duct with Lashley cups: sample 1 without gustatory stimulation during the first 10 minutes and samples 2 and 3 during the next five to 10 minutes, when saliva production was stimulated by a 500 mg vitamin C tablet. The sample volumes were measured and the beta 2 microglobulin concentration was determined by radioimmunoassay. RESULTS--During gustatory stimulation the mean beta 2 microglobulin secretion rate in patients with primary Sjögren's syndrome was 0.31 microgram/min; in normal controls it was 0.14 microgram/min. The sensitivity and specificity of this test were 56 and 87% respectively. The mean salivary flow without stimulation in patients with primary Sjögren's syndrome was lower than that in normal controls, but no difference was found during stimulation. CONCLUSIONS--Our results support the hypothesis of local beta 2 microglobulin production in the parotid gland of patients with primary Sjögren's syndrome. The test cannot be used as a screening test owing to low sensitivity, but it may be used as a supplementary diagnostic test as it has the advantage of being non-invasive.

Full text

PDF
461

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOCH K. J., BUCHANAN W. W., WOHL M. J., BUNIM J. J. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965 May;44:187–231. [PubMed] [Google Scholar]
  2. Berggård I., Bearn A. G. Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids. J Biol Chem. 1968 Aug 10;243(15):4095–4103. [PubMed] [Google Scholar]
  3. Claas F. H., Runia-van Nieuwkoop R., van den Berge W., van Rood J. J. Interaction of penicillin with HLA-A and -B antigens. Hum Immunol. 1982 Aug;5(1):83–90. doi: 10.1016/0198-8859(82)90033-7. [DOI] [PubMed] [Google Scholar]
  4. Cresswell P., Springer T., Strominger J. L., Turner M. J., Grey H. M., Kubo R. T. Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci U S A. 1974 May;71(5):2123–2127. doi: 10.1073/pnas.71.5.2123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fox R. I., Howell F. V., Bone R. C., Michelson P. Primary Sjogren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum. 1984 Nov;14(2):77–105. doi: 10.1016/0049-0172(84)90001-5. [DOI] [PubMed] [Google Scholar]
  6. Fox R. I., Robinson C. A., Curd J. G., Kozin F., Howell F. V. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum. 1986 May;29(5):577–585. doi: 10.1002/art.1780290501. [DOI] [PubMed] [Google Scholar]
  7. Moutsopoulos H. M., Chused T. M., Mann D. L., Klippel J. H., Fauci A. S., Frank M. M., Lawley T. J., Hamburger M. I. Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med. 1980 Feb;92(2 Pt 1):212–226. doi: 10.7326/0003-4819-92-2-212. [DOI] [PubMed] [Google Scholar]
  8. Nissen M. H., Plesner T., Rørth M. Modification of beta 2-microglobulin in serum from patients with small cell carcinoma of the lung--correlation with the clinical course. Clin Chim Acta. 1984 Aug 15;141(1):41–50. doi: 10.1016/0009-8981(84)90165-7. [DOI] [PubMed] [Google Scholar]
  9. Rudney J. D. Implications of a model from olfactory research for the use of secretion rates in salivary studies. Arch Oral Biol. 1990;35(5):365–371. doi: 10.1016/0003-9969(90)90183-b. [DOI] [PubMed] [Google Scholar]
  10. Speight P. M., Kaul A., Melsom R. D. Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome. Ann Rheum Dis. 1992 Apr;51(4):499–502. doi: 10.1136/ard.51.4.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Swaak A. J., Visch L. L., Zonneveld A. Diagnostic significance of salivary levels of beta 2-microglobulin in Sjögren's syndrome. Clin Rheumatol. 1988 Mar;7(1):28–34. doi: 10.1007/BF02284053. [DOI] [PubMed] [Google Scholar]
  12. Talal N., Grey H. M., Zvaifler N., Michalski J. P., Daniels T. E. Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis. Science. 1975 Mar 28;187(4182):1196–1198. doi: 10.1126/science.46621. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES